%D9%83%D8%A7%D9%86%D8%AF%D9%8A%D8%B3%D8%A7%D8%B1%D8%AA%D8%A7%D9%86%DA%A9%D8%A7%D9%86%D8%AF%D8%B3%D8%A7%D8%B1%D8%AA%D8%A7%D9%86Category:CandesartanCandesartanCandesartanCandesartanCandesart%C3%A1n%DA%A9%D8%A7%D9%86%D8%AF%D8%B3%D8%A7%D8%B1%D8%AA%D8%A7%D9%86KandesartaaniCand%C3%A9sartanKandezart%C3%A1nCandesartan%E3%82%AB%E3%83%B3%E3%83%87%E3%82%B5%E3%83%AB%E3%82%BF%E3%83%B3CandesartanumKandesartanCandesartan%D0%9A%D0%B0%D0%BD%D0%B4%D0%B5%D1%81%D0%B0%D1%80%D1%82%D0%B0%D0%BDKandesartanKandesartan%D0%9A%D0%B0%D0%BD%D0%B4%D0%B5%D1%81%D0%B0%D1%80%D1%82%D0%B0%D0%BDCandesartanQ415970%E5%9D%8E%E5%9C%B0%E6%B2%99%E5%9D%A6
about
P3781
Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate HypertensionCandesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate HypertensionEffects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsEffect of Some Drugs on Liver FibrosisCandesartan in Peripheral NeuropathyA Double Blind Randomized Controlled Trial to Assess the Effectiveness and Tolerability of a Quadruple Ultra-low-dose Treatment for HypertensionAcute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and CandesartanPrognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentChanges After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) BlockerPivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, FedCandesartan Preventive Traitement of Peripherical NeuropathyStudy of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionEfficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionAn Investigation on the Effect of Candesartan on Early Diabetic NephropathySingle Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting ConditionsEffects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of HypertensionCognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin SystemComparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic EvaluationThe Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionSafety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgSevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ AmlodipineThe Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)The Potential of Candesartan to Retard the Progression of Aortic StenosisStudy to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in FranceStudy to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323Pharmacokinetic Drug Interaction Between Candesartan and RosuvastatinCandesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"CKD-330 Drug-Drug Interaction Study (Candesartan)CKD-330 Drug-Drug Interaction Study (Amlodipine)A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionMonotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan CilexetilCandesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
P4844
Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers.Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat.Angiotensin II Receptor 1 Blockage Limits Brain Damage and Improves Functional Outcome After Brain Injury in Aged Animals Despite Age-Dependent Reduction in AT1 Expression
P921
description
Arzneistoff
@de
angiotensin II receptor antagonist used mainly for the treatment of hypertension
@en
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Candesartan
@de
Candesartan
@it
Candesartan
@nl
Candesartan
@vi
Candesartanum
@la
Candesartán
@es
Kandesartaani
@fi
Kandesartan
@sh
Kandesartan
@sr
Kandezartán
@hu
type
label
Candesartan
@de
Candesartan
@it
Candesartan
@nl
Candesartan
@vi
Candesartanum
@la
Candesartán
@es
Kandesartaani
@fi
Kandesartan
@sh
Kandesartan
@sr
Kandezartán
@hu
altLabel
2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
@cy
2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
@en
2-ethoxy-1-{[2'-(1H-tetrazol-5 ...... enzimidazole-7-carboxylic acid
@cy
2-ethoxy-1-{[2'-(1H-tetrazol-5 ...... enzimidazole-7-carboxylic acid
@en
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid
@cy
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid
@en
Amias
@es
Atacand
@es
C24H20N6O3
@it
CHARM-Added
@de
prefLabel
Candesartan
@de
Candesartan
@it
Candesartan
@nl
Candesartan
@vi
Candesartanum
@la
Candesartán
@es
Kandesartaani
@fi
Kandesartan
@sh
Kandesartan
@sr
Kandezartán
@hu